...
首页> 外文期刊>Advances in therapy. >Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study
【24h】

Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study

机译:甲状腺癌有益于卵巢癌的预后:基于SEER的研究

获取原文
获取原文并翻译 | 示例

摘要

IntroductionTo explore the effect of a second thyroid cancer (TC) on ovarian cancer (OC) patient survival, we compared OC patients with or without a second primary TC using data from the Surveillance, Epidemiology, and End Results (SEER) database.MethodsData for OC only, female TC only and OC patients with a second TC (OC2TC) from two periods, 2000-2014 and 1980-1994, were extracted from the SEER database. Differences in clinicopathological and treatment characteristics were analysed using the chi-square test. Cox regression analyses were used to identify risk factors associated with OC survival. Disease-specific survival (DSS) and overall survival (OS) curves were compared using the log-rank test.ResultsThere were 109 OC2TC patients from 2000 to 2014, and significant differences (P<0.001) in the mean age at OC diagnosis, TNM stage and surgical history were found between OC and OC2TC patients. Several factors, including age, grade, TNM stage, histological type and surgical history, influenced OC survival (P<0.001). OC2TC patients showed better survival than OC patients from 2000 to 2014, regardless of age, TNM stage or surgical history. However, this superiority was not significant in cases from 1980 to 1994 (P=0.222 for OS).ConclusionSurvival was better with OC2TC than with OC from 2000 to 2014 rather than 1980-1994, suggesting that TC improved the survival of OC patients from 2000 to 2014.
机译:介绍探讨第二次甲状腺癌(TC)对卵巢癌(OC)患者存活的影响,我们将OC患者与来自监测,流行病学和最终结果(SEER)Database.methodsdata的数据进行比较或没有第二初级TC的患者OC仅,从SEER数据库中提取来自两个时期的女性TC和第二次TC(OC2TC)的患者,从SEER数据库中提取。使用Chi-Square试验分析临床病理学和治疗特征的差异。 COX回归分析用于鉴定与OC生存相关的危险因素。使用对数秩检测进行比较疾病特异性存活(DSS)和总存活(OS)曲线。结果是来自2000年至2014年的109名OC2TC患者,并且在OC诊断的平均年龄差异(p <0.001),TNM在OC和OC2TC患者之间发现了阶段和手术病史。几个因素,包括年龄,等级,TNM阶段,组织学类型和外科手术史,影响oC存活(P <0.001)。 OC2TC患者比2000年至2014年的OC患者更好地存活,无论年龄,TNM阶段还是手术史。然而,在1980年至1994年的情况下,这种优势并不重要(对于OS的P = 0.222)。Conclusionsurvival与OC2TC比OC从2000年到2014年而不是1980-1994,表明TC从2000年改善了OC患者的存活率到2014年。

著录项

  • 来源
    《Advances in therapy. 》 |2019年第5期| 共10页
  • 作者单位

    Hangzhou Med Coll Zhejiang Prov Peoples Hosp Dept Gen Surg Hangzhou Zhejiang Peoples R China;

    Fudan Univ Obstet &

    Gynecol Hosp Dept Gynecol Shanghai Peoples R China;

    Hangzhou Med Coll Zhejiang Prov Peoples Hosp Key Lab Gastroenterol Zhejiang Prov Hangzhou;

    Jianghan Univ Mech &

    Elect Engn Inst Wuhan Hubei Peoples R China;

    Hangzhou Med Coll Zhejiang Prov Peoples Hosp Dept Gen Surg Hangzhou Zhejiang Peoples R China;

    Hangzhou Med Coll Zhejiang Prov Peoples Hosp Dept Gen Surg Hangzhou Zhejiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学 ;
  • 关键词

    Ovarian cancer; Survival; Thyroid cancer; TSH suppression therapy;

    机译:卵巢癌;存活;甲状腺癌;TSH抑制疗法;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号